Literature DB >> 10194154

Surfactant protein levels in severe respiratory syncytial virus infection.

M H Kerr1, J Y Paton.   

Abstract

Infection with respiratory syncytial virus (RSV) is a common cause of respiratory disease in infancy. Surfactant phospholipids have been shown to be reduced in severe RSV infection. Reduction in surfactant proteins might also contribute to the pathogenesis of this disease. We investigated daily levels of surfactant proteins in bronchoalveolar lavage (BAL) fluid from 18 ventilated infants with RSV infection (median age 3.1 mo) and in a control group of 16 ventilated surgical patients (median age 0.4 mo). Surfactant proteins were measured by ELISA, total protein by the Lowry method. Surfactant protein A (SP-A) was reduced in BAL fluid from children with RSV infection (median 5.6 micrograms/ml; range 0.6 to 151.9 micrograms/ml) compared with control samples (median 9.0 micrograms/ml; range 0.5 to 139.6 micrograms/ml, p = 0.0368). Surfactant protein B (SP-B) was lower in the RSV group (median 12.0 ng/ml; range 0 to 60. 8 ng/ml) than in control patients (median 118.1 ng/ml; range 0 to 778.2 ng/ml, p < 0.0000). Surfactant protein D (SP-D) was also reduced in the RSV group (median 130.3 ng/ml; range 0 to 1,486.0 ng/ml) versus median 600.4 ng/ml; range 0 to 1,869.0 ng/ml, p < 0. 0000. Total protein levels were higher in the RSV group (median 0.49 mg/ml; range 0.13 to 2.46 mg/ml versus median 0.36 mg/ml; range 0.07 to 1.65 mg/ml, p = 0.0079). The median value of SP-A was significantly lower in the initial sample (2.3 micrograms/ml) than in the final one (6.0 micrograms/ml). However, no significant correlation was found between surfactant protein concentrations and disease severity measured by arterial alveolar oxygen ratio. We conclude that alterations in surfactant protein concentrations are present in severe RSV infection and speculate that these may contribute to the abnormalities of lung function seen in this condition.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10194154     DOI: 10.1164/ajrccm.159.4.9709065

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  31 in total

1.  Heterogeneous pulmonary phenotypes associated with mutations in the thyroid transcription factor gene NKX2-1.

Authors:  Aaron Hamvas; Robin R Deterding; Susan E Wert; Frances V White; Megan K Dishop; Danielle N Alfano; Ann C Halbower; Benjamin Planer; Mark J Stephan; Derek A Uchida; Lee D Williames; Jill A Rosenfeld; Robert Roger Lebel; Lisa R Young; F Sessions Cole; Lawrence M Nogee
Journal:  Chest       Date:  2013-09       Impact factor: 9.410

Review 2.  S-nitrosylation of surfactant protein D as a modulator of pulmonary inflammation.

Authors:  Elena N Atochina-Vasserman
Journal:  Biochim Biophys Acta       Date:  2011-12-13

3.  Differential susceptibility of transgenic mice expressing human surfactant protein B genetic variants to Pseudomonas aeruginosa induced pneumonia.

Authors:  Lin Ge; Xinyu Liu; Rimei Chen; Yongan Xu; Yi Y Zuo; Robert N Cooney; Guirong Wang
Journal:  Biochem Biophys Res Commun       Date:  2015-11-24       Impact factor: 3.575

4.  Proteomic analysis reveals down-regulation of surfactant protein B in murine type II pneumocytes infected with influenza A virus.

Authors:  Lemme P Kebaabetswe; Anoria K Haick; Marina A Gritsenko; Thomas L Fillmore; Rosalie K Chu; Samuel O Purvine; Bobbie-Jo Webb-Robertson; Melissa M Matzke; Richard D Smith; Katrina M Waters; Thomas O Metz; Tanya A Miura
Journal:  Virology       Date:  2015-05-15       Impact factor: 3.616

5.  Epigenetic mechanisms modulate thyroid transcription factor 1-mediated transcription of the surfactant protein B gene.

Authors:  Yuxia Cao; Tiffany Vo; Guetchyn Millien; Jean-Bosco Tagne; Darrell Kotton; Robert J Mason; Mary C Williams; Maria I Ramirez
Journal:  J Biol Chem       Date:  2009-11-10       Impact factor: 5.157

6.  Transmission of surfactant protein variants and haplotypes in children hospitalized with respiratory syncytial virus.

Authors:  Neal J Thomas; Susan DiAngelo; Joseph C Hess; Ruzong Fan; Margaret W Ball; Joseph M Geskey; Douglas F Willson; Joanna Floros
Journal:  Pediatr Res       Date:  2009-07       Impact factor: 3.756

7.  Enhanced surfactant protein and defensin mRNA levels and reduced viral replication during parainfluenza virus type 3 pneumonia in neonatal lambs.

Authors:  Branka Grubor; Jack M Gallup; David K Meyerholz; Erika C Crouch; Richard B Evans; Kim A Brogden; Howard D Lehmkuhl; Mark R Ackermann
Journal:  Clin Diagn Lab Immunol       Date:  2004-05

8.  Motifs within the CA-repeat-rich region of Surfactant Protein B (SFTPB) intron 4 differentially affect mRNA splicing.

Authors:  Wenjun Yang; Lan Ni; Patricia Silveyra; Guirong Wang; Georgios T Noutsios; Anamika Singh; Susan L Diangelo; Olabisi Sanusi; Manmeet Raval; Joanna Floros
Journal:  J Mol Biochem       Date:  2013-02-20

9.  Human respiratory syncytial virus A2 strain replicates and induces innate immune responses by respiratory epithelia of neonatal lambs.

Authors:  Alicia Olivier; Jack Gallup; Marcia M M A de Macedo; Steven M Varga; Mark Ackermann
Journal:  Int J Exp Pathol       Date:  2009-08       Impact factor: 1.925

Review 10.  The host response and molecular pathogenesis associated with respiratory syncytial virus infection.

Authors:  Christine M Oshansky; Wenliang Zhang; Elizabeth Moore; Ralph A Tripp
Journal:  Future Microbiol       Date:  2009-04       Impact factor: 3.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.